Literature DB >> 28529987

The role of radiofrequency ablation to liver transection surface in patients with close tumor margin of HCC during hepatectomy-a case matched study.

C Nicholas Kotewall1, Tan To Cheung1, Wong Hoi She1, Ka Wing Ma1, Simon Hing Ying Tsang1, Jeff Wing Chiu Dai1, Albert Chi Yan Chan2, Kenneth Siu Ho Chok2, Chung Mau Lo3.   

Abstract

BACKGROUND: To review the outcome of using radiofrequency ablation (RFA) for patients with close resection margin during hepatectomy.
METHODS: From Oct 2004 to Sept 2013, 862 patients received hepatectomy for hepatocellular carcinoma (HCC) in the Department of Surgery, Queen Mary Hospital in Hong Kong. Fourteen patients received additional RFA because of close resection margin (<1 cm) during the operation for HCC. The result of 28 patients with close liver resection margin was selected for comparison. The two groups of patients were matched in terms of tumor size, tumor number, stage of disease and magnitude of resection.
RESULTS: In the RFA group (n=14), the median age of the patients was 58.5 (range, 25-78 years). The median tumor size was 2.25 cm (range, 1.2-12 cm). In the resection alone group (n=28), the median age for the patients was 61 (range, 36-79 years). The median tumor size was 2.7 cm (range, 1-11 cm). There was no difference in terms of liver function assessment between the two groups. There was no RFA related complication recorded during the study period. There was no hospital mortality in both groups. The 1- and 3-year disease free survival was 38.3% and 25.5% respectively in the RFA group vs. 57.4% and 39.3% respectively in the liver resection alone group (P=0.563). The 1- and 3-year overall survival was 81.5% and 69.8% respectively in the RFA group vs .88.4% and 59.9% respectively in the liver resection alone group (P=0.83).
CONCLUSIONS: RFA to hepatectomy resection surface in patients with close margin is a safe treatment option but its effectiveness on prevention of local recurrence has yet to be confirmed.

Entities:  

Keywords:  Close resection margin; case-matched study; hepatocellular carcinoma (HCC); radiofrequency ablation (RFA)

Year:  2017        PMID: 28529987      PMCID: PMC5420546          DOI: 10.21037/tgh.2017.03.19

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  24 in total

Review 1.  Radiofrequency thermal ablation of liver tumors.

Authors:  Elisabetta Buscarini; Agostino Savoia; Gianfranco Brambilla; Fernanda Menozzi; Luigi Reduzzi; Deike Strobel; Johannes Hänsler; Luigi Buscarini; Luigi Gaiti; Alessandro Zambelli
Journal:  Eur Radiol       Date:  2005-03-08       Impact factor: 5.315

2.  Safety and efficacy of radiofrequency ablation for periductal hepatocellular carcinoma with intraductal cooling of the central bile duct.

Authors:  Vincent Wai-To Lam; Kelvin Kwok-Chai Ng; Kenneth Siu-Ho Chok; Tan-To Cheung; Jason Wat; Sheung-Tat Fan; Ronnie T P Poon
Journal:  J Am Coll Surg       Date:  2008-05-29       Impact factor: 6.113

3.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

Review 4.  Radiofrequency ablation of malignant liver tumors.

Authors:  S A Curley
Journal:  Oncologist       Date:  2001

5.  Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival.

Authors:  Eric Dupont-Bierre; Philippe Compagnon; Jean-Luc Raoul; Gabriel Fayet; Anne-Sophie de Lajarte-Thirouard; Karim Boudjema
Journal:  J Am Coll Surg       Date:  2005-09-30       Impact factor: 6.113

6.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

7.  Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma.

Authors:  T Matsumata; T Kanematsu; K Takenaka; Y Yoshida; T Nishizaki; K Sugimachi
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

Review 8.  Radiofrequency ablation of primary and metastatic hepatic malignancies.

Authors:  Steven A Curley; Francesco Izzo
Journal:  Int J Clin Oncol       Date:  2002-04       Impact factor: 3.402

9.  Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma.

Authors:  Atsushi Sasaki; Seiichiro Kai; Yukio Iwashita; Seitaro Hirano; Masayuki Ohta; Seigo Kitano
Journal:  Cancer       Date:  2005-01-15       Impact factor: 6.860

Review 10.  Thermal ablative therapy for malignant liver tumors: a critical appraisal.

Authors:  Kelvin Kwok-Chai Ng; Chi-Ming Lam; Ronnie Tung-Ping Poon; Victor Ai; Wai-Kuen Tso; Sheung-Tat Fan
Journal:  J Gastroenterol Hepatol       Date:  2003-06       Impact factor: 4.029

View more
  1 in total

1.  An Optimal Ablative Margin of Small Single Hepatocellular Carcinoma Treated with Image-Guided Percutaneous Thermal Ablation and Local Recurrence Prediction Base on the Ablative Margin: A Multicenter Study.

Authors:  Feng-Yao Li; Jian-Guo Li; Song-Song Wu; Huo-Lin Ye; Xu-Qi He; Qing-Jing Zeng; Rong-Qin Zheng; Chao An; Kai Li
Journal:  J Hepatocell Carcinoma       Date:  2021-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.